Research

rs1050891 — HNMT 3'UTR variant

Histamine breakdown in blood and tissues - uses methyl groups from SAM

Moderate Risk Factor

Details

Gene
HNMT
Chromosome
2
Risk allele
G
Consequence
Regulatory
Inheritance
Codominant
Clinical
Risk Factor
Evidence
Moderate
Chip coverage
v3 v4 v5

Population Frequency

AA
63%
AG
32%
GG
5%

Ancestry Frequencies

south_asian
29%
east_asian
26%
latino
22%
european
20%
african
17%

HNMT - The Tissue Histamine Pathway

Histamine N-methyltransferase (HNMT) is the second major enzyme for degrading histamine in your body. While DAO works in the gut to intercept dietary histamine, HNMT operates inside cells throughout your body - particularly in the brain, liver, kidneys, and bronchial epithelium. It is the dominant pathway for clearing histamine from tissues and the central nervous system.

The Mechanism

HNMT works by transferring a methyl group from S-adenosylmethionine 11 SAM is the body's universal methyl donor, used in hundreds of biochemical reactions (SAM) onto histamine, converting it to N-methylhistamine, which is then further broken down and excreted. The rs1050891 variant is located in the 3' untranslated region 22 The 3'UTR is a regulatory region of mRNA that affects how much protein is produced without changing the protein itself (UTR) of the HNMT gene, which influences mRNA stability and translation efficiency. The G allele reduces HNMT protein production, leading to slower histamine clearance in tissues.

The Methylation Connection

Because HNMT requires SAM as a methyl donor, its function is directly tied to your methylation capacity. If you also carry MTHFR variants (rs1801133 or rs1801131) that reduce methylfolate production, your HNMT may be further compromised by limited methyl group availability. 33 When SAM is scarce, HNMT must compete with dozens of other methyltransferases for the available supply This creates a meaningful interaction between the methylation and histamine pathways.

The Double Hit Scenario

The most clinically significant situation arises when someone has impaired function in both DAO and HNMT pathways. DAO handles dietary histamine in the gut; HNMT handles endogenous and residual histamine in tissues. If both pathways are compromised, histamine can accumulate from multiple sources simultaneously, leading to more pronounced and persistent symptoms.

Practical Implications

Supporting HNMT function means supporting methylation: adequate B12, folate 44 Methylfolate (5-MTHF) is the active form that bypasses the MTHFR enzyme step entirely (ideally as methylfolate if you have MTHFR variants), and riboflavin. If you have both HNMT and DAO variants, a comprehensive approach addressing both diet (low histamine) and methylation support (B vitamins) may be necessary.

Nutrient Interactions

histamine altered_metabolism
vitamin B12 increased_need
folate increased_need
riboflavin increased_need

Genotype Interpretations

What each possible genotype means for this variant:

AA “Full HNMT Activity” Normal

Normal HNMT activity

Your HNMT enzyme functions normally. This enzyme breaks down histamine in your blood and tissues (unlike DAO which works in the gut). It uses SAM (a methyl donor) as a cofactor. About 63% of Europeans share this genotype.

AG “Reduced HNMT Activity” Intermediate Caution

Mildly reduced tissue histamine clearance

You carry one variant reducing HNMT activity. Histamine in your blood and tissues may clear more slowly, especially if you also have methylation issues (HNMT uses methyl groups). About 32% of Europeans share this genotype.

GG “Low HNMT Activity” Reduced Warning

Reduced tissue histamine clearance

You have two HNMT variants. Combined with any DAO variants, this creates a "double hit" that significantly increases histamine sensitivity risk. About 5% of Europeans have this genotype.

Key References

PMID: 17490952

Maintz & Novak review describing dual DAO/HNMT histamine degradation pathways

PMID: 9547362

Preuss et al. characterization of HNMT pharmacogenetics and common polymorphisms that alter activity

PMID: 21040557

Garcia-Martin et al. study of HNMT and DAO gene polymorphisms in childhood allergic asthma